Mario Alfonso Inclán Nafría

The work of Dr. Mario Inclán (H index = 14) is centred on the biomedical applications of Supramolecular Chemistry. It has led to the publication of 33 scientific articles and one patent. The relevance of his contributions is evidenced by the more than 512 citations received and the fact that 25 of them have been published in the top 25% (Q1) journals of their category. Moreover, his results have been presented in the form of oral communications in more than 22 national and international congresses, as well as posters and press releases in various media. Among his works as a first author, it is worth mentioning the one published in the prestigious JACS (Inclán, M., et al. J. Am. Chem. Soc. 2012, 134, 9644) that has received more than 96 citations. In this ground-breaking paper, Dr. Inclán demonstrates, for the first time, how induced molecular reorganizations can be used to modulate the cytotoxicity of antitumour compounds. He is now trying to expand the application of these “synthetic allosteric systems” to the fight against antimicrobial resistant pathogens, a novel and original approach to this problematic.
As a postdoctoral researcher, Dr. Inclán was awarded in 2016 a Marie S. Curie fellowship at the Institute of Nanoscience and Nanotechnology in Athens, Greece. After a paternity leave, he was reincorporated to his Host Institution in 2018 as a postdoctoral researcher. In 2019 he was awarded a third postdoctoral fellowship from the Generalitat Valenciana (APOSTD2019) and has enjoyed a one-year postdoctoral stay in the group of Prof. Pau Ballester (ICIQ, Tarragona). Dr. Inclán is now participating in national (MINECO), regional (PROMETEO) and European (COST Action) projects and has built an extensive network of international scientific collaborations.
His research has a clear impact in society since most of his results have biomedical implications. As a co-inventor of two patents related to antiparasitic and antifungal compounds for Tropical Neglected Diseases, Dr. Inclán is making great efforts to advance this technology, which is expected to have a great positive impact in health-care systems, particularly for developing countries.
Dr. Inclán is now a Professor at University CEU Cardenal Herrera, where he is a memeber of the Encapsulation Technologies (TENCAP) research group. He also participates as Vice-Chair for the European Commission, assisting the Research Executive Agency (REA) in the MSCA-PF calls.